Towards regulatory cellular therapies in solid organ transplantation

Towards regulatory cellular therapies in solid organ transplantation

Organ transplantation is a modern medical success story. However, since its inception it has been limited by the need for pharmacological immunosuppression. Regulatory cellular therapies offer an attractive solution to these challenges by controlling transplant alloresponses through multiple paralle...

Full description

Bibliographic Details
Main Authors:	Bottomley, MJ, Brook, MO, Shankar, S, Hester, J, Issa, F
Format:	Journal article
Language:	English
Published:	Cell Press 2021

Similar Items

Cellular therapies in organ transplantation
by: Hoogduijn, MJ, et al.
Published: (2021)

Regulatory B cells in transplantation: roadmaps to clinic
by: Beckett, J, et al.
Published: (2020)

CD4+ regulatory T cells in solid organ transplantation.
by: Issa, F, et al.
Published: (2010)

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients
by: Brook, MO, et al.
Published: (2022)

Opportunities for high-plex spatial transcriptomics in solid organ transplantation
by: Cross, AR, et al.
Published: (2023)

Regulatory T cells in experimental solid organ transplantation
by: Chan, T
Published: (2018)

Homing of regulatory T cells to human skin is important for the prevention of alloimmune-mediated pathology in an in vivo cellular therapy model.
by: Issa, F, et al.
Published: (2012)

The potential role for regulatory T-cell therapy in vascularized composite allograft transplantation.
by: Issa, F, et al.
Published: (2014)

Late treatment with autologous expanded regulatory T-cell therapy after alemtuzumab induction is safe and facilitates immunosuppression minimization in living donor renal transplantation
by: Brook, MO, et al.
Published: (2024)

Regulatory T-cell therapy approaches
by: McCallion, O, et al.
Published: (2022)

Chimeric antigen receptors and regulatory T cells: the potential for HLA-specific immunosuppression in transplantation
by: Wright, S, et al.
Published: (2021)

Regulatory immune cells in transplantation.
by: Wood, K, et al.
Published: (2012)

IL‐33 drives the production of mouse regulatory T cells with enhanced in vivo suppressive activity in skin transplantation
by: Kawai, K, et al.
Published: (2020)

Feasibility, long‐term safety and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients
by: Harden, PN, et al.
Published: (2020)

Regulatory T cells and organ transplantation.
by: Waldmann, H, et al.
Published: (2004)

Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and may associate with malignancy risk in long-term renal transplant recipients
by: Bottomley, MJ, et al.
Published: (2022)

Regulatory T cells: potential in organ transplantation.
by: Wood, K, et al.
Published: (2004)

Immune monitoring for advanced cell therapy trials in transplantation: which assays and when?
by: Stark, HL, et al.
Published: (2021)

Investigation of CD27-CD70 co-stimulation in human regulatory T cells for enhanced cellular therapy in transplantation
by: Arroyo Hornero, RC
Published: (2019)

Immunobiology of solid organ transplantation.
by: Turvey, SE, et al.
Published: (1999)

Cell therapy : stem cell transplantation, gene therapy, and cellular immunotherapy /
by: Morstyn, George, 1950-, et al.
Published: (1996)

Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and associates with malignancy risk in long-term renal transplant recipients
by: Bottomley, M, et al.
Published: (2022)

Deciphering the contribution of γδ T cells to outcomes in transplantation
by: McCallion, O, et al.
Published: (2018)

Induction of transplantation tolerance through regulatory cells: from mice to men.
by: Ferrer, I, et al.
Published: (2014)

Regulatory cell therapy in kidney transplantation (The ONE Study): A harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
by: Sawitzki, B, et al.
Published: (2020)

Tissue targeted regulatory T cell therapy prevents human skin allograft rejection in a humanised mouse model
by: Issa, F, et al.
Published: (2013)

Regulatory T cells for tolerance
by: Kawai, K, et al.
Published: (2017)

Regulatory T cells in transplantation.
by: Wood, K
Published: (2011)

Regulatory cells in transplantation.
by: Wood, K, et al.
Published: (2003)

Regulatory T cells in transplantation
by: Wood, K
Published: (2011)

Regulatory T cells in transplantation.
by: Waldmann, H, et al.
Published: (2006)

Regulatory T cells in transplantation.
by: Karim, M, et al.
Published: (2002)

An exploration of regulatory T cells in transplantation: cell therapy development and immune monitoring
by: Alzhrani, AI
Published: (2021)

Modulation of CD27/CD70 co-stimulatory pathway may allow for the generation of a more potent human regulatory T cell product for cell therapy
by: Arroyo Hornero, R, et al.
Published: (2017)

BIOMARKERS OF OPERATIONAL TOLERANCE IN SOLID ORGAN TRANSPLANTATION.
by: Heidt, S, et al.
Published: (2012)

Enhancing human regulatory T cells in vitro for cell therapy applications
by: Milward, K, et al.
Published: (2017)

An investigation of regulatory T cell therapy in advanced human skin experimental transplantation models
by: Adigbli, G
Published: (2022)

Regulatory T cells in transplantation tolerance.
by: Wood, K, et al.
Published: (2003)

Regulatory cells and transplantation tolerance.
by: Cobbold, S, et al.
Published: (2013)

Regulatory T cells and transplantation tolerance.
by: Cobbold, S
Published: (2008)